Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,223.5
18.9 (0.59%)

 

  • STI Straits Times Index
    3,223.5
    18.9 (0.59%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,585.2
    1.0 (0.07%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,652.4
    -385.9 (-1.48%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,565.8
    -31.8 (-0.89%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,010.0
    -96.0 (-0.33%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,605.4
    -51.5 (-0.77%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 818.6M
  • Value: 503.9M
  • Rise: 157
  • Fall: 101
  • Unch: 493

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Koh Eco0.070+0.013
Tritech0.027+0.004
Raffles Edu0.071+0.012
Vividthree0.073+0.028
GKE0.147+0.008
Zhongxin Fruit0.053+0.008
ThaiBev0.730+0.015
Progen0.054+0.003
Boldtek0.112+0.003
Sunrise Shares0.089+0.006

World Indices

World Indices
Name Last Change
Nasdaq 15,235.7 +9.0
HSI 25,629.7 -408.6
HSCEI 9,097.3 -162.1
Jakarta 6,605.4 -51.5
Nikkei 225 29,058.5 -47.5
SSE Comp 3,563.4 -34.3
Shanghai A 3,734.5 -36.0
Shanghai B 276.2 -1.1
KOSPI 3,025.8 -23.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Yunnan Energy YUNNAN ENERGY INTL CO. LIMITED
Quotes 10 Minutes Delayed. Updated at 27 Oct 2021 08:51
Last (SGD): 0.169 Change: - High: - Remarks: -
Change (%): - Low: -
Open - Yesterday's Close 0.169
Buy Price 0.083 Sell Price -
Buy Volume ('000) 30.0 Sell Volume ('000) -
Cumulative Volume ('000) - Cumulative Value -
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.03850 Trailing EPS (SGD) e -0.05244 NAV (SGD) b 0.1177
PE a - Trailing PE f - Price / NAV b 1.4359
Dividend (SGD) d - Cash In Hand (SGD) g - Issued & Paid-up Shares c 275,437,000
Dividend Yield (%) d - Price / Cash In Hand g - Treasury Shares h -
Beta - 75 Daysi - R-Squared - 75 Days(%)i - Market Cap (M) 46.549
Beta - 500 Daysi -0.368 R-Squared - 500 Days (%)i 1.09 Enterprise Value (M) 35.778
Piotroski F Score 4 Exchange Code T43 Par Value ( USD ) 0.05000
52 Weeks Volatility (%) 113.8302 6-Month VWAP 0.124 Free Float (%) 27.0
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Wholesale and Retail Trade - Medical Specialties
Category Classification China
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 05 Oct 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Yunnan Energy SGX 46.549 - - 1.4359 -
Industry China SGX 798.198 24.556 23.917 0.7496 3.364
Medical Specialties SGX 1,255.133 2.669 2.703 3.0956 20.705
Local Peer Top Glove SGX 6,966.176 2.737 2.737 3.5714 21.809
Local Peer UGHealthcare SGX 203.365 1.712 1.712 1.0669 1.548
Local Peer Medtecs Intl SGX 202.172 1.161 1.389 0.8054 18.236
Local Peer Biolidics SGX 52.825 - - 10.0000 -
Local Peer Annica SGX 16.675 - - 5.0000 -
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 239,332.514 37.542 27.842 6.4941 0.146
Global Peer ABBOTT LABORATORIES NYSE 227,151.427 50.783 31.461 - 1.193
Global Peer DANAHER CORP NYSE 219,325.119 62.486 38.330 5.4582 0.233
Global Peer MEDTRONIC PLC NYSE 166,947.731 46.297 42.995 3.2426 1.950
Global Peer INTUITIVE SURGICAL INC NASDAQ 124,476.136 117.364 73.689 10.9085 -
Global Peer STRYKER CORP NYSE 103,015.085 64.425 49.455 7.4541 0.860
Global Peer EDWARDS LIFESCIENCES CORP NYSE 72,923.143 88.564 49.865 14.2059 -
Global Peer BECTON DICKINSON & CO NYSE 70,749.257 92.241 37.935 2.9316 1.312
Global Peer BOSTON SCIENTIFIC CORP NYSE 63,105.032 - 134.840 3.9584 -
Global Peer IDEXX LABORATORIES INC NASDAQ 55,466.084 95.339 76.206 74.2061 -
Other Global Peers DEXCOM INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), ALCON AG (NYSE), BAXTER INTERNATIONAL INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), STERIS PLC (NYSE), BIO RAD LABORATORIES INC (NYSE), WATERS CORP (NYSE), PERKINELMER INC (NYSE), INSULET CORPORATION (NASDAQ), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), ABIOMED INC (NASDAQ), MASIMO CORPORATION (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), DENTSPLY SIRONA INC (NASDAQ), QIAGEN NV (NYSE), NOVOCURE LTD (NASDAQ), BRUKER CORPORATION (NASDAQ), COCHLEAR LTD (ASX), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), MICROPORT SCIENTIFIC CORPORATION (HKEx), TANDEM DIABETES CARE INC (NASDAQ), GLOBUS MED INC (NYSE), SHANDONG WEIGAO GROUP MEDICAL (HKEx), SHOCKWAVE MEDICAL INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), ANGELALIGN TECHNOLOGY INC (HKEx), STEVANATO GROUP S.P.A. (NYSE), INMODE LTD (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), STAAR SURGICAL CO (NASDAQ), QUIDEL CORP (NASDAQ), TOPGLOV (Bursa), HARTA (Bursa), ICU MEDICAL INC (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), NEOGEN CORP (NASDAQ), INARI MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), CONMED CORP (NYSE), NEVRO CORP (NYSE), EBOS GROUP (ASX), MERIT MEDICAL SYSTEMS (NASDAQ), CAREDX INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), HAEMONETICS CORP (NYSE), ATRICURE INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), HESKA CORP (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), LIFETECH SCIENTIFIC CORP (HKEx), SILK ROAD MEDICAL INC (NASDAQ), GLAUKOS CORPORATION (NYSE), VENUS MEDTECH (HANGZHOU) INC (HKEx), IRHYTHM TECHNOLOGIES INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), BUTTERFLY NETWORK INC (NYSE), PROCEPT BIOROBOTICS CORP (NASDAQ), MICROPORT CARDIOFLOW MEDTECH CORP (HKEx), PEIJIA MEDICAL LIMITED (HKEx), MESA LABORATORIES INC (NASDAQ), AVANOS MEDICAL INC (NYSE), ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY (HKEx), LANTHEUS HOLDINGS INC (NASDAQ), PULMONX CORPORATION (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), KANGJI MEDICAL HLDGS LTD (HKEx), PARAGON 28 INC (NYSE), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), CUE HEALTH INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), ATRION CORP (NASDAQ), NANOSONICS LIMITED (ASX), SIGHT SCIENCES INC (NASDAQ), AK MEDICAL HLDGS LTD (HKEx), LEMAITRE VASCULAR INC (NASDAQ), SUPERMX (Bursa), ALPHATEC HLDGS INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), VIEWRAY INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), ANGIODYNAMICS INC (NASDAQ), VICARIOUS SURGICAL INC (NYSE), CERUS CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), SEMLER SCIENTIFIC INC (NASDAQ), CHINA ISOTOPE & RADIATION CORP (HKEx), INOGEN INC (NASDAQ), DERMTECH INC (NASDAQ), 908 DEVICES INC (NASDAQ), BEIJING CHUNLIZHENGDA MED INST CO (HKEx), BIOVENTUS INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), CRYOLIFE INC (NYSE), SISRAM MEDICAL LTD (HKEx), ORASURE TECHNOLOGIES INC (NASDAQ), SURMODICS INC (NASDAQ), MODERN DENTAL GROUP LIMITED (HKEx), CUTERA INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), BRONCUS HOLDING CORPORATION (HKEx), INTERCURE LTD (NASDAQ), SI BONE INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), PULSE BIOSCIENCES INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), NYXOAH SA (NASDAQ), SHANGHAI KINDLY MED INSTRS CO LTD (HKEx), AXOGEN INC (NASDAQ), ACOTEC SCIENTIFIC HLDGS LTD (HKEx), VAPOTHERM INC (NYSE), SEASPINE HOLDINGS CORP (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), PAVMED INC (NASDAQ), SHANGHAI HEARTCARE MEDICAL TECHNOLO (HKEx), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), IRADIMED CORP (NASDAQ), METRICS INCOME OPPORTUNITIES TRUST (ASX), MISONIX INC (NASDAQ), SOLITON INC (NASDAQ), ZYNEX INC (NASDAQ), STEREOTAXIS INC (NYSE American), AVITA MEDICAL INC (NASDAQ), SUZHOU BASECARE MEDICAL CORP LTD (HKEx), LUCID DIAGNOSTICS INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), NEUROPACE INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), EARGO INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), SIENTRA INC (NASDAQ), CVRX INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), RETRACTABLE TECHNOLOGIES INC (NYSE American), YESTAR HEALTHCARE HOLDINGS CO LTD (HKEx), ONCOCYTE CORP (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), AROA BIOSURGERY LTD (ASX), PROFOUND MED CORP (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), QUOTIENT LTD (NASDAQ), PW MEDTECH GROUP LIMITED (HKEx), CYTOSORBENTS CORP (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ICECURE MEDICAL LTD (NASDAQ), LUCIRA HEALTH INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), CONFORMIS INC (NASDAQ), CLARITY PHARMACEUTICALS LTD (ASX), IMPEDIMED LIMITED (ASX), TITAN MEDICAL INC (NASDAQ), CORMEDIX INC (NASDAQ), TELA BIO INC (NASDAQ), INTRICOM CORP (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), INVACARE CORP (NYSE), EMVISION MEDICAL DEVICES LTD (ASX), SOMNOMED LIMITED (ASX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), CYCLOPHARM LIMITED (ASX), NEURONETICS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), KELFRED HOLDINGS LTD (HKEx), IRIDEX CORP (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), FONAR CORP (NASDAQ), CRYO-CELL INTERNATIONAL INC (NASDAQ), MICRO-X LTD (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), VENUS CONCEPT INC (NASDAQ), OPTISCAN IMAGING (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), CLEANSPACE HOLDINGS LTD (ASX), RGTBHD (Bursa), ALPHA PRO TECH (NYSE American), ENVVENO MED CORP (NASDAQ), VOLITIONRX LIMITED (NYSE American), SDI LTD (ASX), BIOLASE INC (NASDAQ), ELECTROMED INC (NYSE American), MEDAVAIL HOLDINGS INC (NASDAQ), CHECK-CAP LTD (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), LENSAR INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), CELSION CORPORATION (NASDAQ), VINCENT MEDICAL HOLDINGS LTD (HKEx), NEPHROS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), IMMUCELL CORP (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), AVINGER INC (NASDAQ), DIMERIX LTD (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), ELECTROCORE INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), BIOMERICA INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), NEOVASC INC (NASDAQ), CARDIEX LTD (ASX), NEUROMETRIX INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), APPLIED UV INC (NASDAQ), COMPUMEDICS (ASX), EKSO BIONICS HOLDINGS INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), RESHAPE LIFESCIENCES INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), DAXOR CORP (NYSE American), NUTRIBAND INC (NASDAQ), RESONANCE HEALTH LTD (ASX), YUNNAN ENERGY INTL CO LTD (HKEx), TENAX THERAPEUTICS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), RESPIRI LTD (ASX), BELLEROPHON THERAPEUTICS INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), ADVENTA (Bursa), INSPIREMD INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), DYNATRONICS CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), LIFE HEALTHCARE GROUP LTD (HKEx), PETVIVO HLDGS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), VIVEVE MEDICAL INC (NASDAQ), LKL (Bursa), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), ADHERIUM LIMITED (ASX), XTANT MEDICAL HLDGS INC (NYSE American), NUWELLIS INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE American), TRUSCREEN GROUP LTD (ASX), OVENTUS MEDICAL LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), CYANOTECH CORP (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), METALICITY LIMITED (ASX), USCOM LTD (ASX), HUAKANG BIOMEDICAL HLDGS CO LTD (HKEx), STAR EQUITY HOLDINGS INC (NASDAQ), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days ---
20 Days ---
Medium Term Return 3 Months ---
6 Months -+0.101
+148.53 %
1 Year -+0.040
+31.01 %
Long Term Return 2 Years -+0.010
+6.29 %
3 Years --0.396
-70.09 %
5 Years --0.071
-29.58 %
Annualised Return Annualised --
-6.77 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.059 - 0.169 Change From 1 Year Low +0.110 % Change From 1 Year Low (%) +186.44
Change From 1 Year High - % Change From 1 Year High (%) -
2 Years Range 0.059 - 0.169 Change From 2 Years Low +0.110 % Change From 2 Years Low (%) +186.44
Change From 2 Years High - % Change From 2 Years High (%) -
5 Years Range 0.059 - 0.695 Change From 5 Years Low +0.110 % Change From 5 Years Low (%) +186.44
Change From 5 Years High -0.526 % Change From 5 Years High (%) -75.68
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Company was incorporated in Bermuda on 26 January 2004 under the name of Techcomp (Holdings) Limited. The Group is principally engaged in the design, development, manufacture and distribution of analytical instruments, life science equipment and laboratory instruments. It designs and manufactures various instruments, including gas and ion chromatographs, UV-Vis spectrophotometers and centrifuges for its house brand "Techcomp". The Group also manufactures for Hitachi High-Technologies Corporation on an original design manufacture ("ODM") basis. The Group’s manufacturing and distribution products address the academic, industrial, pharmaceutical, biotechnology and other research and laboratory markets, as well as the clinical laboratory and healthcare industries, agricultural and environmental industries, and government agencies. The Group’s products are used in industries and government agencies which conduct identification, quantification, material preparation and analysis of the elemental, molecular, physical, or biological composition or structure of liquids, solids, or gases. The Group has manufacturing operations in Shanghai and Tianjin. It has various technological partnerships and alliances, including agreements with Hitachi Naka Instrument Co Ltd for the development of UV-Vis spectrophotometers, Hitachi Koki Co Ltd for the development of centrifuges, and Alltech for the development of chromatographs.The Group distributes analytical instruments, life science equipment and laboratory instruments to customers in China, Hong Kong, Japan, Europe, the United States, Southeast Asia, South Asia and Australia through its trading subsidiaries located in Tianjin, Shanghai, Guangzhou, Hong Kong and Singapore, and its 11 liaison offices in China. Through its subsidiaries and third party distributors, it is also able to offer its customers maintenance and application support and repair services for all the products manufactured and distributed.

To more accurately reflect the Group’s current business activities and direction of future development, the company has changed its name from “Techcomp (Holdings) Limited” to “Yunnan Energy International Co. Limited”. Trading under new name with effect from 12 Dec 2018.

IPO Performance

Listing Date 12 Jul 2004 Full Subscription Rate (x) 5.42
No of Placement Shares (M) 37.00 No of Public Offer Shares (M) 3.00 Public Offer Subscription Rate (x) 59.90
IPO Price (SGD) a 0.267 First Day Close (SGD) a 0.290 First Week Close (SGD) a 0.253
Current vs IPO Price (%) -36.70 First Day Gain (%) +8.61 First Week Gain (%) -5.24
Notes:
  1. Adjusted for the following: Bonus Issue 1 for 2 on 04/05/2010

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2020 Dec 2020 Part 1(1.19 MB)
Part 2(1.37 MB)
Part 3(0.66 MB)
Part 4(0.91 MB)
Annual Report 2019 Dec 2019 Part 1(6.54 MB)
Part 2(6.60 MB)
Part 3(0.28 MB)
Part 4(0.50 MB)
Annual Report 2018 Dec 2018 Part 1(1.26 MB)
Part 2(1.42 MB)
Part 3(0.29 MB)
Part 4(0.51 MB)
Annual Report 2017 Dec 2017 Part 1(5.92 MB)
Part 2(6.03 MB)
Part 3(0.10 MB)
Part 4(0.20 MB)
Annual Report 2016 Dec 2016 Part 1(4.85 MB)
Part 2(0.10 MB)
Part 3(4.15 MB)
Part 4(0.21 MB)
Annual Report 2015 Dec 2015 Part 1(2.46 MB)
Part 2(0.10 MB)
Part 3(2.98 MB)
Part 4(0.20 MB)
Annual Report 2014 Dec 2014 Part 1(1.72 MB)
Annual Report 2013 Dec 2013 Part 1(4.97 MB)
Part 2(0.05 MB)
Part 3(0.13 MB)
Annual Report 2012 Dec 2012 Part 1(1.04 MB)
Annual Report 2011 Dec 2011 Part 1(1.21 MB)
Annual Report 2010 Dec 2010 Part 1(0.91 MB)
Annual Report 2009 Dec 2009 Part 1(3.10 MB)
Annual Report 2008 Dec 2008 Part 1(1.76 MB)
Annual Report 2007 Dec 2007 Part 1(1.33 MB)
Annual Report 2006 Dec 2006 Part 1(1.05 MB)
Annual Report 2005 Dec 2005 Part 1(1.25 MB)
Interim Report
Interim Report 2021 Jun 2021 Part 1(1.75 MB)
Part 2(1.12 MB)
Interim Report 2020 Jun 2020 Part 1(0.53 MB)
Part 2(1.18 MB)
Interim Report 2019 Jun 2019 Part 1(0.77 MB)
Part 2(1.41 MB)
Interim Report 2018 Jun 2018 Part 1(1.65 MB)
Part 2(1.08 MB)
Interim Report 2017 Jun 2017 Part 1(0.88 MB)
Part 2(1.38 MB)
Interim Report 2016 Jun 2016 Part 1(0.18 MB)
Part 2(0.62 MB)
Interim Report 2015 Jun 2015 Part 1(0.49 MB)
Part 2(1.44 MB)
Interim Report 2014 Jun 2014 Part 1(0.22 MB)
Part 2(0.72 MB)
Interim Report 2013 Jun 2013 Part 1(1.02 MB)
Interim Report 2012 Jun 2012 Part 1(0.16 MB)
IPO Prospectus
IPO Prospectus 2004 Jul 2004 Part 1(2.46 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
26 Oct 2021 0.169 0.169 0.169 0.169 - -
25 Oct 2021 0.169 0.169 0.169 0.169 - -
22 Oct 2021 0.169 0.169 0.169 0.169 - -
21 Oct 2021 0.169 0.169 0.169 0.169 - -
20 Oct 2021 0.169 0.169 0.169 0.169 - -
19 Oct 2021 0.169 0.169 0.169 0.169 - -
18 Oct 2021 0.169 0.169 0.169 0.169 - -
15 Oct 2021 0.169 0.169 0.169 0.169 - -
14 Oct 2021 0.169 0.169 0.169 0.169 - -
13 Oct 2021 0.169 0.169 0.169 0.169 - -
12 Oct 2021 0.169 0.169 0.169 0.169 - -
11 Oct 2021 0.169 0.169 0.169 0.169 - -
08 Oct 2021 0.169 0.169 0.169 0.169 - -
07 Oct 2021 0.169 0.169 0.169 0.169 - -
06 Oct 2021 0.169 0.169 0.169 0.169 - -
05 Oct 2021 0.169 0.169 0.169 0.169 - -
04 Oct 2021 0.169 0.169 0.169 0.169 - -
01 Oct 2021 0.169 0.169 0.169 0.169 - -
30 Sep 2021 0.169 0.169 0.169 0.169 - -
29 Sep 2021 0.169 0.169 0.169 0.169 - -
28 Sep 2021 0.169 0.169 0.169 0.169 - -
27 Sep 2021 0.169 0.169 0.169 0.169 - -
Summary
Current 2 Weeks
(13 Oct 2021 to 26 Oct 2021)
0.169 0.169 0.169 0.169 - -
Previous 2 Weeks
(29 Sep 2021 to 12 Oct 2021)
0.169 0.169 0.169 0.169 - -
4 Weeks from
(01 Sep 2021 to 28 Sep 2021)
0.169 0.169 0.169 0.169 - -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.